Valuation: Bioneer Corporation

Market Cap 149B 105M 90.87M 84.39M 77.82M 147M 9.99B 149M 999M 391M 4.96B 393M 384M 16.68B P/E 2024
-23.6x
P/E 2025 -117x
Enterprise Value 163B 114M 99.32M 92.23M 85.06M 160M 10.92B 163M 1.09B 428M 5.42B 429M 420M 18.23B EV / Sales 2024
1.59x
EV / Sales 2025 1.04x
Free-Float
82.04%
Yield 2024 *
-
Yield 2025 -
1 day-1.03%
1 week-3.82%
Current month-15.35%
1 month-17.76%
3 months-46.93%
6 months-59.05%
Current year-54.59%
1 week 5,470
Extreme 5470
6,690
1 month 5,470
Extreme 5470
7,100
Current year 5,470
Extreme 5470
14,210
1 year 5,470
Extreme 5470
15,640
3 years 5,470
Extreme 5470
47,700
5 years 5,470
Extreme 5470
98,800
10 years 4,355
Extreme 4355
98,800
Manager TitleAgeSince
Chief Executive Officer 64 01/08/1992
Corporate Officer/Principal 62 28/03/2024
Corporate Officer/Principal 51 31/03/2025
Director TitleAgeSince
Director/Board Member 64 18/02/2011
Director/Board Member 61 01/05/1997
Director/Board Member 63 01/02/2000
Date Insider Type Main position Quantity % Market Cap.
12/06/25 Fiscal year

Director

2,625 0.0102%
03/03/25 Buy

Chief Executive Officer

3,000 0.0116%
22/01/25 Buy 1,579 0.0061%
Change 5-day change 1-year change 3-year change Capi.($)
-1.03%-3.82%-61.37%-86.63% 104M
-0.81%-0.33%+27.15%+81.12% 55.6B
-3.74%-6.32%+42.70%+64.45% 55.2B
-0.11%+0.86%-15.63%-13.56% 23.51B
-1.58%-5.51%-3.51%+375.36% 22.35B
+1.69%-1.59%+19.50%-12.74% 20.6B
-1.23%-3.15%+26.00%-31.88% 17.45B
+0.21%-6.07%+16.06%+539.05% 15.16B
+1.16%+0.58%+51.87%+181.96% 13.91B
-5.09%-10.87%+153.11%+272.20% 13.74B
Average -1.03%-2.32%+25.59%+136.93% 23.76B
Weighted average by Cap. -1.36%-0.46%+30.88%+125.22%

Financials

2024 2025
Net sales 294B 206M 179M 166M 153M 288M 19.65B 294M 1.97B 769M 9.76B 773M 756M 32.82B 330B 231M 201M 186M 172M 324M 22.06B 330M 2.21B 864M 10.96B 868M 849M 36.85B
Net income -20.58B -14.41M -12.52M -11.62M -10.72M -20.19M -1.38B -20.56M -138M -53.88M -683M -54.11M -52.93M -2.3B -2.81B -1.97M -1.71M -1.59M -1.46M -2.76M -188M -2.81M -18.81M -7.36M -93.38M -7.4M -7.23M -314M
Net Debt -20.54B -14.38M -12.49M -11.6M -10.7M -20.15M -1.37B -20.51M -137M -53.76M -682M -53.99M -52.81M -2.29B 13.9B 9.73M 8.45M 7.85M 7.24M 13.63M 929M 13.88M 92.91M 36.38M 461M 36.54M 35.74M 1.55B
Logo Bioneer Corporation
Bioneer Corp is a Korea-based company engaged in the biotechnology business. The Company mainly operates genetic research, molecular diagnostics, probiotics, and ribonucleic acid interference (RNAi) new drug development businesses. The Company mainly provides services such as gene analysis and synthesis, gene expression, and protein expression and purification. The Company’s products include body fat-reducing lactic acid bacteria in probiotics field, and basic materials, reagents, kits, gene extraction, amplification, quantitative analysis equipment, molecular diagnosis equipment for genetic research and molecular diagnosis used in molecular diagnosis field. The Company also provides laboratory equipment, single products, and laboratory consumables used in biotech research.
Employees
392
Date Price Change Volume
30/07/26 ₩5,790.00 -1.03% 74,477
29/07/26 ₩5,850.00 -6.55% 141,791
28/07/26 ₩6,260.00 -3.54% 46,319
27/07/26 ₩6,490.00 +1.72% 42,526
24/07/26 ₩6,380.00 -0.31% 44,605
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A064550 Stock